US Earnings Financial Results SEC Filings — March 25, 2026

25-03-2026

Spectral AI's R&D revenue declined 33.6% YoY to $19.65M in 2025 from $29.58M in 2024, resulting in gross profit falling to $8.93M (down 32.7% YoY) despite a slight gross margin improvement to 45.4% from 44.9%. Operating loss widened to $8.60M from $6.58M, but net loss narrowed to $7.57M from $15.16M, driven by favorable changes in warrant liabilities and other income. Adjusted EBITDA deteriorated to $(7.42M) from $(5.54M).

• ·Dependence on BARDA contract as largest single source of revenue, not guaranteed to be fully awarded or extended.
• ·2024 financials reflect $157K adjustment to income tax provision.
• ·Favorable $7.88M YoY change in fair value of warrant liabilities contributed to net loss improvement.

25-03-2026

UiPath reported total revenue of $1.61B for FY2026 ended January 31, 2026, up 13% YoY from $1.43B, driven by 19% growth in subscription services to $954M, while licenses grew modestly 3% to $606M and professional services rose 23% to $50M. The company achieved profitability with operating income of $57M (4% margin) versus a $163M loss (-11% margin) and net income of $282M versus a $74M loss, aided by lower operating expenses (down to 79% of revenue from 94%) including reduced stock-based compensation and restructuring costs. However, cost of professional services increased to 7% of revenue from 5%, and other expense worsened.

• ·Amortization of acquired intangible assets totaled $8.2M in FY2026, up from $6.7M.
• ·Stock-based compensation expense decreased to $291M from $358M YoY.
• ·Restructuring expenses fell sharply to $4.4M from $25M.
• ·Benefit from income taxes was $182M in FY2026.

25-03-2026

Social Commerce Partners Corp (SCPQ), a SPAC, reported total assets of $101.1M as of December 31, 2025, including $100.1M in marketable securities held in the Trust Account from its IPO proceeds of $98.0M net plus $3.5M private placement. The company incurred a net loss of $0.58M for the period from inception (August 11, 2025) through year-end, driven by $0.52M compensation expense and $0.13M G&A costs, offset slightly by $0.06M interest income, resulting in a shareholders' deficit of $2.6M. Cash position stood at $1.0M outside the Trust, with no prior periods for comparison.

• ·Loss from operations: $0.64M
• ·Interest income: $59,591
• ·Deferred underwriting fee: $3.5M
• ·Net cash used in operating activities: $73,500
• ·Basic and diluted net loss per share: $0.15 (Class A and Class B)
• ·Net cash provided by financing activities: $101.1M

25-03-2026

Vector 21 Holdings, Inc. reported no revenue for FY ended June 30, 2025, with a reduced net loss of $23,966 (down 40% YoY from $40,273) due to lower G&A expenses ($24,326 vs. $38,833). However, cash and cash equivalents depleted to $0 from $52, total liabilities rose 18% to $155,965 driven by higher accounts payable and related-party loans, and shareholders' deficit worsened to $(155,965). The company qualifies as an inactive registrant with minimal activity.

• ·Accounts payable and accruals increased to $72,106 from $51,832.
• ·Loan payable-related party rose to $32,399 from $28,399.
• ·Promissory note-related party slightly declined to $51,460 from $51,820.
• ·No investing activities in either year.
• ·Net cash from financing activities dropped sharply to $4,000 from $22,080.

25-03-2026

CoJax Oil & Gas Corp's FY 2025 net loss narrowed to $1.11M from $1.61M in FY 2024 (-31.1% YoY), supported by a 56.4% drop in impairment expense to $402K and 15.7% lower G&A expenses at $776K, alongside positive operating cash flow of $41K versus a $19K outflow. However, revenues were nearly flat at $964K (-0.8% YoY), lease operating expenses increased 17.5% to $418K, total assets declined to $9.58M from $10.51M, and stockholders' equity fell to $7.85M from $8.62M.

• ·Proved properties at cost: $8.1M (2025) vs $8.9M (2024)
• ·Accumulated depletion: ($900K) (2025) vs ($767K) (2024)
• ·Accounts receivable net: $110K (2025) vs $147K (2024)
• ·Common stock issued for accrued salaries: $340K (2025)

25-03-2026

Range Capital Acquisition Corp. reported net income of $4.0M for the year ended December 31, 2025, a turnaround from a $39K loss in the period from inception (July 24, 2024) through December 31, 2024, primarily driven by $4.8M in interest earned on the Trust Account. However, operating costs increased significantly to $803K from $147K over the comparable periods, resulting in a larger operating loss. The Trust Account balance grew to $120.5M as of December 31, 2025, from $100.6M a year earlier, with redemption value rising to $10.48 per share.

• ·Up to $1.5M in non-interest bearing loans from initial shareholders, officers, or directors may be convertible into working capital units at $10.00 per unit.
• ·Shareholders’ equity decreased to $211K as of Dec 31, 2025 from $847K as of Dec 31, 2024.
• ·Over-allotment option liability settled to $0 from $148K.

25-03-2026

Pure Storage, Inc. reported total revenue of $3.66B for FY2026, up 16% YoY from $3.17B in FY2025, driven by 16% growth in product revenue to $1.97B and 15% in subscription services revenue to $1.69B; subscription ARR also grew 16% YoY to $1.92B. However, operating expenses increased notably with R&D up 20% to $725M, sales and marketing up 17% to $1.08B, and total cost of revenue up 14% to $1.08B, while gross margins remained flat at 70%. Net cash from operating activities improved to $880M, though financing cash use deepened.

• ·Product gross margin improved slightly to 67% from 66% YoY.
• ·Subscription services gross margin flat at 74% YoY.
• ·G&A expenses increased 10% YoY to $229M.
• ·Net cash used in investing activities improved to $(108M) from $(218M).
• ·Net cash used in financing activities increased to $(645M) from $(510M).

25-03-2026

Concord Acquisition Corp II reported net income of $556,003 for FY 2025, a turnaround from a $766,076 loss in FY 2024, driven by a 41% reduction in operating costs to $1.265M and positive changes in fair value of financial instruments. However, cash in Trust Account plummeted 99.6% to $99,373 amid $23.8M withdrawals related to redemptions that reduced redeemable shares from 2.2M to 8,550, leaving total assets at just $354k versus $24.7M prior year, with cash declining 63% to $197k. Stockholders’ deficit improved slightly to $(8.75M) from $(8.97M), but liquidity remains critically low.

• ·Excise tax payable increased to $2.86M at Dec 31, 2025 from $2.46M.
• ·Capital Contribution Note fair value decreased to $1.96M from $3.54M.
• ·Warrant liability decreased to $604K from $737K.
• ·Net cash used in operating activities improved to $929K used from $1.55M used.
• ·Federal income tax paid $20K in 2025 vs $671K in 2024.

25-03-2026

Range Capital Acquisition Corp II (RNGTW), a SPAC, reported total assets of $233.4M as of December 31, 2025, with $232.1M held in the Trust Account from 23M Class A ordinary shares at $10.09 redemption value. For the period from inception (May 22, 2025) through year-end, the company posted net income of $1.8M driven by $2.1M interest income, but incurred an operating loss of $0.3M from G&A expenses, resulting in a shareholders' deficit of $6.9M.

• ·Cash balance: $1.1M; Prepaid expenses: $85K; Long-term prepaid insurance: $53K
• ·Accounts payable and accrued expenses: $11K; Accrued offering costs: $75K
• ·Basic and diluted EPS for Class A and B shares: $0.12
• ·Possible working capital loans up to $1.5M convertible into units at $10.00 per unit

25-03-2026

Aldel Financial II Inc., a blank check company (SPAC), filed its 10-K for the year ended December 31, 2025, reporting no principal operations and a trust account balance of $243.0M (approximately $10.57 per public share), up from $231.2M initially funded post-IPO due to interest income. The company raised $230.0M gross proceeds from its October 23, 2024 IPO of 23.0M units at $10.00 each (including over-allotment) and $7.1M from private placements, while holding $0.5M cash outside the trust. It continues seeking a business combination in financial services within a 24-month window, with no redemptions or withdrawals from trust for taxes to date.

• ·IPO registration statement effective Oct 21, 2024; Public Warrants exercisable at $11.50/share after BC or 12 months post-IPO.
• ·24-month period to complete initial Business Combination (from Oct 23, 2024).
• ·No interest withdrawn from trust for taxes as of Dec 31, 2025.
• ·Sponsor transferred 690,000 founder shares to management and board on Aug 13, 2024.

25-03-2026

Morgan Stanley Capital I Trust 2019-H6 filed its 10-K annual report on March 25, 2026, containing Regulation AB servicing criteria compliance assertions from servicers Midland, K-Star, PBLS, an unnamed Company, and CoreLogic. Most criteria are affirmed as performed directly or by responsible vendors, while others are designated N/A, not performed by the servicer, or inapplicable depending on the entity. No material non-compliance, deficiencies, or exceptions are reported across the board.

• ·Multiple criteria marked N/A (e.g., back-up servicer requirements, investor reporting specifics) or 'NOT performed' by certain servicers where inapplicable to their role.
• ·Footnotes referenced (e.g., 1,2,3,4,i,Xi) for certain assertions, but details truncated.

25-03-2026

Securetech Innovations, Inc. (SCTH) reported audited FY2025 revenue of $7.7 million, substantially all from AI UltraProd, acquired on June 23, 2025, which now serves as its primary operating business. The company outlined a 2026 roadmap including NASDAQ uplisting in Q2, expansions into U.S. and Indonesian markets, an investor awareness program starting late February, and M&A targeting $5-10M revenue companies. However, it highlighted extensive risks such as material weaknesses in internal controls, dependence on key personnel like J. Scott Sitra, potential market non-acceptance, and challenges with inventory management and competition.

• ·Piranha Blockchain is an early-stage enterprise focused on digital-asset infrastructure and cybersecurity.
• ·Terra Nova Technologies (Top Kontrol) is a legacy product line undergoing restructuring for planned spin-off to OTCQB.
• ·Product revenue streams include one-time cybersecurity sales, subscription services, cryptocurrency ventures, and transaction fees.

25-03-2026

Braze, Inc. (BRZE) reported FY2026 revenue of $738.2M, up 24.4% YoY from $593.4M in FY2025, with gross profit rising 20.8% to $495.7M. However, cost of revenue increased 32.4% to $242.5M, causing gross margin to contract slightly to 67.1% from 69.1%, while operating loss widened to $144.8M from $122.2M and net loss grew to $130.8M from $104.0M amid elevated operating expenses (up to 87% of revenue from 90%). Positively, net cash provided by operating activities more than doubled to $71.4M from $36.7M, and non-GAAP free cash flow improved to $58.1M from $19.6M.

• ·Sales and marketing expenses reached $327.0M in FY2026, up from $247.1M in FY2024.
• ·Research and development expenses increased to $167.1M in FY2026 from $119.9M in FY2024.
• ·Total operating expenses were 87% of revenue in FY2026, improved from 99% in FY2024.
• ·Net cash used in investing activities was $50.9M in FY2026, up from $20.0M in FY2024.

25-03-2026

AAR Corp's Q3 FY26 sales surged 25% YoY to $845.1M, with products up 30% to $539.5M and services up 17% to $305.6M, driving net income of $68.0M versus a $8.9M loss prior year; nine-month sales grew 18% to $2.38B with net income $137.0M versus $21.5M loss. However, Q3 operating income fell 7% YoY to $65.8M amid SG&A expenses rising 47% to $89.8M, and nine-month cash from operations was modest at $43.4M after $222M acquisition outflow and $24.6M capex. Balance sheet expanded with total assets at $3.33B (up 17% QoQ) and equity $1.64B (up 36%), but inventories rose 19% to $958.2M and cash declined to $78.5M.

• ·Equity offering proceeds funded growth, with common stock issued increasing to 48.8M shares from 45.3M.
• ·Net cash used in investing activities $251.8M for nine months, primarily acquisitions.
• ·Purchase price for recent acquisition $78.0M net of cash acquired, with net assets $113.7M.

25-03-2026

HNO International reported no revenue for the three months ended January 31, 2026 or 2025, resulting in a net loss of $182,069, a 96.7% improvement from the prior year's $5.46M loss, driven by sharply lower operating expenses ($188K vs. $5.45M). Cash balance increased to $81K from $10K QoQ, supported by $198K in financing inflows, though total assets declined 20% QoQ to $1.39M amid a stockholders' deficit widening slightly to $1.70M. Operating cash burn improved to $126K from $168K YoY but remains negative with ongoing reliance on related party advances and stock sales.

• ·Convertible note payable converted to 193,164 common shares under Regulation A.
• ·Related party advances increased by $130K during Q1 2026.
• ·Property and equipment, net declined to $1.26M from $1.32M QoQ due to $65K depreciation.
• ·Unregistered sales: 500,000 shares to Raymond Renfrow (Reg D, Nov 2025), 33,334 shares to Kevin Bens (Reg A, Dec 2025), 333,334 shares to Tri-Bridge Ventures, LLC (Reg A, Jan 2026).

25-03-2026

byNordic Acquisition Corp reported a widened net loss of $731,544 for the year ended December 31, 2025, compared to $206,537 in 2024, primarily due to a 74% decline in interest income to $398,336 amid a 53% drop in Trust Account balance to $5.5M following redemptions of shares. While operating costs improved 27% YoY to $1.06M and cash balance rose 24% to $338K, total liabilities increased 11% to $14.7M driven by higher related-party promissory notes ($7.7M, up 23%), and stockholders' deficit deepened to $14.4M.

• ·Deferred underwriters’ discount remained at $6.0M as of Dec 31, 2025.
• ·Excise tax payable decreased to $70,197 from $295,573 YoY.
• ·Net cash used in operating activities improved to $1.1M from $3.0M YoY.

25-03-2026

KIORA Pharmaceuticals reported zero revenue in 2025 compared to $16M in 2024, resulting in a net loss of $10.8M versus a $3.6M profit the prior year, driven by the absence of collaboration revenue and higher R&D expenses up 37% to $10.8M. While cash and equivalents rose to $8.7M from $3.8M supported by investing activities, total assets declined to $24.3M from $36.5M and operating cash flow swung to a $10M use from $8.6M provided.

• ·Basic EPS declined to -$2.60 from $0.93 YoY.
• ·In-Process R&D Impairment increased to $4.6M from $2.0M.
• ·Stockholders’ Equity decreased to $16.1M from $25.8M.
• ·Short-Term Investments fell to $8.4M from $23.0M.

25-03-2026

Maze Therapeutics reported a net loss of $131.1M for 2025 compared to net income of $52.2M in 2024, driven by the absence of $167.5M license revenue recognized in 2024 and a 30% increase in R&D expenses to $108.4M amid clinical investments; total operating expenses rose 30% to $142.9M. The company went public with a net IPO proceeds of $127.8M and a concurrent private placement raising $141.3M, boosting stockholders' equity to $355.0M from a $311.2M deficit and total assets to $397.1M, though cash and equivalents slightly declined to $189.2M with $112.0M operating cash burn.

• ·IPO involved issuance of 8,750,000 common shares.
• ·Private placement: 4,000,002 common shares and pre-funded warrants.
• ·R&D components: Personnel-related costs $45.8M (+32%), clinical trials $18.5M (+76%), facilities flat at ~$21M.
• ·Stock-based compensation expense $16.4M in 2025 (up from $9.6M).
• ·Weighted-average basic shares: 43.0M in 2025 vs 2.4M in 2024; basic EPS $(3.05) vs $1.42.

25-03-2026

Chewy, Inc. reported FY2025 net sales of $12,601.5M, up 6.2% YoY from $11,861.3M, with growth in Consumables (+4.5%), Hardgoods (+13.4%), and Pet health and specialty products (+11.8%), though the Other segment declined 4.7%. Adjusted EBITDA increased 26.1% to $719.2M and free cash flow rose 24.3% to $562.4M, but net income dropped 43.3% to $222.8M from $392.7M, with diluted EPS falling 42.9% to $0.52 due to higher share-based compensation expense of $311.2M. Active customers grew 4.0% to 21.327M, and Autoship sales surged 11.8% to $10,497.1M, representing 83.3% of net sales.

• ·Share-based compensation expense was $311.2M in FY2025, down from $332.1M in FY2024.
• ·Capital expenditures were $129.2M in FY2025, compared to $143.8M in FY2024.
• ·Net cash provided by operating activities increased 16.0% to $691.6M in FY2025.
• ·Gross profit margin improved to 29.8% in FY2025 from 29.2% in FY2024.

25-03-2026

Serina Therapeutics reported total revenues of $0.13M for the year ended December 31, 2025, up $0.07M or 132% YoY from $0.06M in 2024 due to higher grant revenues. However, operating expenses rose 41% to $24.2M, driven by a 76% increase in R&D to $13.2M and 14% rise in G&A to $11.0M, resulting in a widened net loss of $19.2M from $11.2M YoY. Net cash used in operating activities increased slightly 4.8% to $18.0M, though the net decrease in cash improved 84% to $0.6M from $3.9M.

• ·Net cash provided by financing activities increased 31.8% to $17.4M in 2025 from $13.2M in 2024.
• ·Other income, net declined $1.0M or 17.4% to $4.8M in 2025.
• ·Net cash used in investing activities increased 168.2% to $0.06M in 2025.

25-03-2026

Modiv Industrial, Inc. reported AFFO attributable to common stockholders and OP Unit holders of $17,238 for the year ended December 31, 2025, up 15.1% from $14,988 in 2024, driven by adjustments such as amortization of off-market interest rate derivatives. However, GAAP net income declined sharply 91.5% to $554 from $6,493 due to a $5,814 impairment of real estate investment property and lower gain on sales ($2,520 vs. $3,360), with total revenue slightly down 0.8% to $46,387 from $46,761. Total assets decreased 6.2% to $476,457 and total equity fell 5.6% to $202,045, while FFO was nearly flat down 1.9% at $16,489 from $16,802.

• ·Net cash provided by investing activities increased to $27,801 in 2025 from $8,395 in 2024.
• ·Net cash used in financing activities widened to $39,917 in 2025 from $18,235 in 2024.
• ·Mortgage notes payable, net decreased to $11,994 from $30,777.
• ·Credit facility term loan, net slightly increased to $249,489 from $248,999.
• ·FFO per fully diluted share/unit: $1.32 in 2025 vs. $1.50 in 2024.
• ·AFFO per fully diluted share/unit: $1.38 in 2025 vs. $1.34 in 2024.
• ·Rental revenue: $45,823 in 2025 vs. $46,497 in 2024 (down 1.4%).
• ·Preferred stock dividends: $3,202 in 2025 vs. $3,688 in 2024.

25-03-2026

ECB Bancorp reported strong improvements in asset quality with non-performing assets declining 42% to $1,139 thousand (0.07% of total assets) at December 31, 2025 from $1,957 thousand (0.14%), and net interest income surging 29% to $31,160 thousand driven by 14% loan growth to average $1,263M and higher yields (5.47% vs 5.24%). Noninterest income rose 8.2% to $1,326 thousand. However, noninterest expenses increased 3.2% to $21,330 thousand, with notable rises in FDIC deposit insurance (+17.4%) and advertising (+16.0%), while some items like director compensation declined 4.4%.

• ·Non-accrual one-to-four family residential loans declined to $1,096 thousand from $1,872 thousand at Dec 31.
• ·Home equity lines non-accrual declined to $43 thousand from $85 thousand at Dec 31.
• ·Income from bank-owned life insurance nearly flat at $475 thousand vs $473 thousand (+0.4%).
• ·Computer software and licensing fees slightly declined 0.5% to $441 thousand.
• ·Short-term investments yield declined to 4.33% from 5.25%.
• ·Savings accounts interest rate declined to 2.03% from 2.72%.
• ·Money market accounts interest rate declined to 3.30% from 3.58%.
• ·Certificates of deposit interest rate declined to 4.15% from 4.34%.

25-03-2026

Steele Creek Capital Corp's 10-K annual report filed on March 25, 2026, details requirements to qualify as a Regulated Investment Company (RIC), including the 90% Income Test for gross income sources, asset diversification with at least 50% in cash equivalents and no more than 5% in any one issuer's securities or 10% of its voting securities, and defines small solvent companies with total assets not exceeding $4 million and capital/surplus of at least $2 million. Risk factors highlight portfolio vulnerability to economic slowdowns or recessions potentially leading to loan repayment failures and financial losses, heavy reliance on Investment Advisor systems and third-party providers that could disrupt operations, and unreliable valuations for OID instruments and PIK securities due to collectability judgments.

25-03-2026

Winnebago Industries reported net revenues of $657.4 million for the three months ended February 28, 2026, up 6.0% YoY from $620.2 million, with net income of $4.8 million versus a prior-year loss of $0.4 million; operating income rose 51.3% to $11.8 million. However, Towable RV segment revenues declined 9.0% to $262.4 million while Motorhome RV grew 29.4% to $304.7 million and Marine dipped 3.0% to $79.2 million. For the six months, revenues increased 9.2% to $1,360.1 million and net income turned positive at $10.3 million from a $5.6 million loss, though cash equivalents fell sharply to $47.4 million from $174.0 million.

• ·Long-term debt reduced to $442.3 million from $540.5 million at August 30, 2025.
• ·Net cash used in operating activities improved to $0.6 million from -$27.2 million for six months.
• ·Inventories increased to $407.6 million from $396.4 million.
• ·Common stock dividends declared at $0.35 per share for the quarter.

25-03-2026

For the twelve months ended December 31, 2025, Global Self Storage, Inc. reported revenues of $12,631,502, up 1.4% YoY, with net operating income increasing 0.6% to $7,767,100 and AFFO rising to $4,402,971 from $4,259,327; however, net income declined to $2,038,451 from $2,123,743, and Q4 revenues fell 0.9% to $3,140,574 with NOI down 4.1% to $1,903,543. Overall square foot occupancy improved slightly to 93.0% from 92.9%, but total assets decreased to $64,072,646 from $65,515,024. FFO per share increased to $0.36 from $0.35, while EPS dipped to $0.18 from $0.19.

• ·Depreciation and amortization remained flat at approximately $1.45M annually.
• ·Note payable decreased to $15,785,874 from $16,356,582.
• ·Weighted average diluted shares outstanding: 11,224,476 for 2025 vs 11,143,831 for 2024.
• ·Cash and cash equivalents increased to $7,364,963 from $7,180,857.

25-03-2026

Armata Pharmaceuticals reported grant revenue of $4.9M for 2025, down 5.2% YoY from $5.2M, while operating expenses decreased 12.8% to $41.5M, driven by a 31.1% drop in R&D to $23.7M, resulting in a smaller operating loss of $36.6M (13.7% improvement). However, a $121.0M negative change in fair value of the Convertible Loan, coupled with higher interest expense up 54.4% to $16.6M, led to a sharply widened net loss of $173.8M (818.8% worse YoY) and stockholders' deficit ballooning to $218.6M from $48.0M.

• ·Cash, cash equivalents and restricted cash decreased to $14.1M from $14.8M YoY.
• ·Term debt increased to $103.1M non-current in 2025 from $22.5M.
• ·Impairment expense of $5.4M recognized in 2025 (none in 2024).
• ·Net loss per share basic $4.80 in 2025 vs $0.52 in 2024.
• ·Proceeds from term debt $25.0M in financing activities 2025.

25-03-2026

Planet 13 Holdings Inc. listed 16 wholly-owned subsidiaries focused on cannabis operations including license holding, retail sales, cultivation, processing, and related activities in Nevada, California, Illinois, and Florida. The filing outlines extensive risk factors, including federal cannabis prohibition, regulatory compliance challenges, competition, operational dependencies, and lack of profitability assurances, with no positive financial performance metrics highlighted. It details the VidaCann acquisition with total consideration of $50,755,443, comprising $4,000,000 cash, 81,872,252 common shares valued at $42,123,314, and a $4,632,129 note payable.

• ·Two subsidiaries listed as inactive: ORB13T LLC and Club One Three, LLC.
• ·Compliance measures include inventory tracking to prevent diversion and policies against distribution to minors or criminal enterprises.
• ·Reliance on Co-CEOs for significant shareholder influence.

25-03-2026

EDAP TMS SA reported total revenues of $70.5M for FY 2025, up 1.6% YoY from $69.4M, driven by strong HIFU segment growth to $37.4M (+45% YoY), but offset by declines in ESWL to $7.5M (-23% YoY) and DISTRIBUTION to $25.7M (-24% YoY). Gross profit improved to $30.0M (42.5% margin) from $28.7M (41.4%), however operating expenses rose to $54.7M leading to a larger operating loss of $24.7M and net loss of $29.2M versus prior year figures of $22.2M and $20.6M respectively. Cash and equivalents ended at $20.5M, down from $31.0M amid ongoing cash burn in operations.

• ·Net cash used in operating activities: $(16,409) thousand in 2025 vs $(14,703) thousand in 2024.
• ·Total current liabilities: $37,141 thousand FY2025 vs $39,280 thousand FY2024.
• ·Long-term debt: $18,023 total, with $15,903 non-current FY2025.
• ·Accumulated deficit: $(128,616) thousand FY2025 vs $(99,370) thousand FY2024.
• ·Basic loss per share: $(0.78) FY2025 vs $(0.55) FY2024.

25-03-2026

Cohen Circle Acquisition Corp. II, a SPAC, filed its 10-K annual report on March 25, 2026, detailing sponsor arrangements with Cohen Circle Sponsor II, LLC and Cohen Circle Advisors II, LLC, including $30,000 monthly for office and administrative services, 8,673,333 Class B Ordinary Shares issued for $25,000, and 445,000 Placement Units for $4,450,000. Permitted withdrawals from trust interest are limited to $400,000 annually for working capital and taxes. Founder shares held by sponsor and insiders such as Betsy Z. Cohen and Daniel G. Cohen face transfer restrictions until post-business combination conditions, including a $12.00 share price threshold, are met.

• ·Transfer restrictions on founder shares expire on the earlier of one year post-initial business combination or if Class A share price meets or exceeds $12.00 for 20 trading days within a 30-day period starting 150 days after combination.
• ·Sponsor loans may cover transaction costs for initial business combination.
• ·Financial statements include Balance Sheets (F-3), Statements of Operations (F-4), Statements of Changes in Shareholders’ Equity (F-5), and Statements of Cash Flows (F-6).

25-03-2026

The 10-K Annual Report for GS Mortgage Securities Trust 2015-GC30, filed on March 25, 2026, contains assertions from Midland and management regarding compliance with servicing criteria under Item 1122(d). Most criteria for general servicing considerations and cash collection/administration were marked as performed directly (X) or by responsible vendors, with minor instances noted as N/A (e.g., back-up servicer requirements) or inapplicable. The filing includes a schedule listing numerous SLM Student Loan Trusts, Navient trusts, Synchrony trusts, and others, indicating related securitized pools.

• ·Filing date: March 25, 2026
• ·Specific servicing criteria with N/A: 1122(d)(1)(iii) back-up servicer in some tables
• ·Criteria 1122(d)(2)(vi) unissued checks safeguarding appears only in one exhibit

25-03-2026

Equillium, Inc. reported no revenue in 2025 ($0) compared to $41,095 in 2024, with total operating expenses declining 52% to $23,634 due to sharp cuts in R&D (down 66% to $12,843), though net loss widened to $(22,398) from $(8,067). Cash position strengthened to $30,277 (up from $18,085) driven by $30,427 in financing activities including a private placement, resulting in net cash increase of $12,192 versus a $5,131 decrease prior year; however, cash used in operations rose to $(22,746) from $(19,026). Stockholders' equity grew to $28,597 from $19,061, supported by increased shares outstanding to 61,464,368.

• ·Private placement net proceeds: $27,909
• ·ATM facility net proceeds: $290 (issuance) + $682 (financing)
• ·Short-term investments declined to $0 from $4,490
• ·Total liabilities decreased to $3,290 from $6,543
• ·Accumulated deficit increased to $(216,205) from $(193,807)
• ·Interest income declined to $833 from $1,381

25-03-2026

Dyadic International Inc. (DYAI) filed its 10-K annual report on March 25, 2026, detailing extensive business and financial risks, including a history of net losses, dependency on a small number of customers, need for substantial additional capital, competitive pressures, and potential failure to commercialize technologies. The company highlights risks from international operations, key personnel loss, cybersecurity, and product liability, with no expectation of paying cash dividends. While advancing the Dapibus™ platform through engineering new strains, improving genetic tools, and optimizing processes for commercial applications, the filing emphasizes volatility in stock price and operating results without providing specific financial metrics.

25-03-2026

Gulf Coast Ultra Deep Royalty Trust reported total assets of $1,083,556 as of December 31, 2025, up 4.6% from $1,036,027 at year-end 2024, with operating cash rising 31% to $20,419 and reserve fund cash increasing 4.2% to $1,063,137. However, the trust corpus deficit widened 63% to ($547,702) from ($336,061), interest income declined 74% to $978, the note payable to HOGA doubled to $416,489, administrative expenses totaled $562,619 (down 37% YoY), and distributable income remained at $0 for the second year. Royalty trust units outstanding were flat at 230,172,696.

• ·Reserve fund liability increased to $1,214,769 as of Dec 31, 2025 from $1,172,088 as of Dec 31, 2024.
• ·Administrative expenses in excess of income improved to ($561,641) in 2025 from ($895,718) in 2024.

25-03-2026

Toppoint Holdings Inc. reported expansions including a new Import Drayage partnership managing 200+ monthly loads, generating $983,515 in additional 2025 revenue, and launched Refrigerated Logistics for cold-chain services to diversify revenue. However, the company faces significant risks from its brokerage model reliant on owner-operators, fuel price fluctuations impacting margins, customer concentration in a few large clients, supply chain disruptions, and higher equipment costs. It maintains healthy cash flows from operations, independence from factoring, and a top 'Satisfactory' DOT safety rating.

• ·Potential fourfold growth in import loads from new partnership
• ·Maintains 'Satisfactory' DOT Safety Rating, the highest available
• ·Positive cash flows fund operations without factoring dependency
• ·Requires DOT/FMCSA-compliant drug testing and annual driver training

25-03-2026

BANK5's 10-K filing includes Appendix B, which details compliance with Regulation AB Rule 1122(d) servicing criteria across multiple servicers including the Company, Midland, Berkadia, and CoreLogic. The majority of criteria in areas such as general servicing considerations, cash collection, and pool asset administration are marked as performed directly by the servicer or by vendors for which they are responsible, while several investor remittances and reporting criteria (e.g., 1122(d)(3)(i)(B)-(D), (ii)-(iv)) are noted as not performed or N/A. No material deficiencies or exceptions are highlighted in the disclosures.

• ·Filing date: March 25, 2026
• ·Multiple criteria marked N/A or not performed, including back-up servicer maintenance (1122(d)(1)(iii)) and certain external enhancements (1122(d)(4)(xv))

25-03-2026

SOLV Energy, Inc.'s 10-K filing highlights significant risks including project delays, cost overruns, revenue reductions from estimate changes, and long sales cycles requiring upfront investments that may not yield projects. However, the company emphasizes its lifecycle approach, differentiating it as the only top five EPC provider offering O&M services at scale, generating recurring revenues through multi-year O&M contracts (minimum 5 years) where corrective maintenance has equaled 70-90% of fixed fees since January 2022. It cites industry data showing opportunities in repowering amid rising power prices (+45% from 2020-2024) despite falling battery prices (-30%).

• ·O&M contracts have a minimum term of five years and typically renew automatically for successive one-year terms.
• ·Company positions itself as the only top five EPC that offers O&M at scale and vice versa.

25-03-2026

25-03-2026

GCT Semiconductor Holding, Inc. reported a sharp 69% YoY decline in total net revenues to $2,866 from $9,128, with product revenues down 76% to $1,131 and service revenues down 60% to $1,735, resulting in a gross loss of $1,817 versus a $5,076 profit in 2024. Net loss widened dramatically to $43,372 from $12,379, exacerbated by a 91% increase in operating expenses to $34,723 and higher interest expense, while cash and cash equivalents dropped to $590 from $1,435. Total assets fell to $15,644 from $19,897, liabilities rose to $98,937 from $79,212, and stockholders' deficit deepened to $83,293 from $59,315.

• ·Net cash used in operating activities remained high at $30,675 in 2025, similar to $30,957 in 2024.
• ·Proceeds from issuance of common stock and warrants in registered direct offering: $11,000 in 2025.
• ·Borrowings increased to $56,589 (current) in 2025 from $37,626 in 2024.
• ·Stock-based compensation expense rose to $6,330 in 2025 from $2,700 in 2024.

25-03-2026

The 10-K annual report for Morgan Stanley Bank of America Merrill Lynch Trust 2013-C12 includes Appendix B, which details compliance assertions for servicing criteria under Regulation AB Item 1122(d) by multiple servicers including the Company, CWCAM, CoreLogic, and Midland. Most applicable criteria are marked as performed directly by the servicer or by responsible vendors, while others such as back-up servicer maintenance, certain investor reporting elements, and external enhancements are deemed inapplicable or not performed. No material noncompliance or deficiencies are indicated in the tables.

• ·Servicing criteria timeframes include deposits/postings within 2 business days, reconciliations within 30 calendar days, and resolution of reconciling items within 90 calendar days where applicable.
• ·Multiple criteria related to investor remittances and reporting (e.g., 1122(d)(3)(i)(B)-(D), (ii)-(iv)) are marked as inapplicable or not performed by several servicers.

25-03-2026

REED'S, INC. reported net sales of $34,065 for the year ended December 31, 2025, down 10% YoY from $37,954, driven by a 9% decline in total cases sold to 1,951 (Reed’s -3%, Virgil’s -18%). Gross profit fell 39% to $6,962 (20% of net sales vs 30% prior year) due to COGS rising to 80% of net sales, while operating expenses increased 13% to $22,110, resulting in an operating loss of $15,148 (87% worse) and net loss of $15,842 (20% worse than $13,152). EBITDA deteriorated to $(14,612) from $(7,267), though interest expense improved sharply by 86%.

• ·Selling and marketing expenses rose 20% YoY to $5,271 (15% of net sales vs 12%).
• ·General and administrative expenses increased 24% YoY to $11,296 (33% of net sales vs 24%).
• ·Loss per share improved to $(1.91) from $(9.81) due to 519% increase in weighted average shares outstanding.
• ·Risk factors include ongoing losses, supply chain challenges, indebtedness restrictions, and potential delisting from NYSE American.

25-03-2026

Texas Community Bancshares, Inc. (TCBS) reported a profitable year in 2025 with net income of $2,842 thousand, reversing a $1,305 thousand loss in 2024, driven by higher net interest income of $13,314 thousand (up 6%) and positive noninterest income of $3,079 thousand versus a $1,903 thousand loss, alongside NIM expansion to 3.26%. However, total assets declined 3% to $429,842 thousand, deposits fell 2% to $327,904 thousand, and nonperforming assets surged 316% to $11,407 thousand or 2.65% of total assets from 0.62%, primarily due to foreclosures adding $9,271 thousand in other real estate owned. Loans grew 3% to $303,205 thousand net, with commercial real estate increasing to $61.5 million (20.1% of loans) from $56.1 million, while construction and land loans declined to $48.4 million (15.8%) from $54.1 million.

• ·Nonaccrual loans decreased to $2,014 thousand from $2,125 thousand.
• ·Provision for credit losses increased to $831 thousand from $158 thousand.
• ·Total capital to risk-weighted assets improved to 16.67% from 15.60%.
• ·Net charge-offs to average loans were -0.17% in 2025 versus -0.05% in 2024.
• ·Premises and equipment net book value: Main office $1,668 thousand; Lindale branch $4,062 thousand.

25-03-2026

The 10-K annual report for GS Mortgage Securities Trust 2013-GC13, filed on March 25, 2026, contains management's assertions and third-party reports on compliance with servicing criteria under Item 1122 of Regulation AB. Multiple tables detail which criteria (e.g., monitoring triggers, custodial accounts, fidelity bonds) are performed directly by the asserting party, via responsible vendors, by non-responsible parties, or deemed inapplicable/not performed, with several marked as 'NOT performed' including back-up servicer maintenance and certain cash administration tasks. No financial performance metrics, delinquencies, or changes are disclosed in the provided excerpts.

• ·Several servicing criteria, such as 1122(d)(1)(iii) (back-up servicer maintenance), are marked as NOT performed by the company, subservicers, or retained vendors.
• ·CoreLogic asserts direct performance for criteria including fidelity bonds (1122(d)(1)(iv)), wire disbursements (1122(d)(2)(ii)), and custodial accounts at federally insured institutions (1122(d)(2)(v)), but NOT performed for others like advances (1122(d)(2)(iii)) and account separation (1122(d)(2)(iv)).

25-03-2026

BeyondSpring Inc. reported no revenue in either 2025 or 2024, with net loss narrowing 15% YoY to $14,217 thousand from $16,693 thousand, aided by a $6,986 thousand gain on sale of subsidiary interests in discontinued operations despite a 60% higher loss from discontinued operations. R&D expenses rose 66% to $4,388 thousand while G&A fell 25% to $4,557 thousand, resulting in a slightly wider 2% operating loss; cash used in operations increased to $19,769 thousand from $16,443 thousand. Liquidity deteriorated with a net cash decrease of $3,909 thousand versus $1,703 thousand prior year, supported by positive investing cash flow of $10,787 thousand.

• ·Revenue remained at zero for both periods.
• ·Income tax expenses: $90 thousand in 2025 vs. $96 thousand in 2024 (-6%).
• ·Net cash provided by financing activities declined to $4,968 thousand from $26,785 thousand.

25-03-2026

MaxCyte's 10-K outlines key risks including heavy dependence on limited products like instruments and PAs prone to quarterly fluctuations, potential system defects harming reputation and sales, funding needs that could dilute shareholders or impose covenants, and customer slowdowns reducing demand. However, competitive strengths feature an innovative SPL model with 31 agreements offering greater than $2B in pre-commercial milestones, 13 active clinical programs with over $130M potential upon approvals, and over $30M in milestones received to date. The company employs 91 full-time staff with deep expertise, including 50 advanced degrees and 23 Ph.D.s, supporting recurring revenue visibility from licenses and consumables.

• ·Delays or inability to obtain acceptance of FDA Master File or equivalent files in foreign jurisdictions could negatively impact SPL customers' clinical trials and MaxCyte's revenues.
• ·Academic institution customers may face decreases in government R&D funding, leading to reduced demand, longer sales cycles, and collection difficulties.

25-03-2026

ProMIS Neurosciences Inc. reported a net loss of $39,719,147 for the year ended December 31, 2025, compared to net income of $2,778,873 in 2024, primarily due to total operating expenses rising 139% to $40,167,308 driven by research and development expenses surging 214% to $33,379,321, while general and administrative expenses increased 10% to $6,787,987. Cash and total assets declined sharply to $6,116,556 and $9,182,421 from $13,291,167 and $18,911,456, respectively, with net cash decreasing by $7,174,611 versus an increase of $693,021 prior year; operating cash use edged up to $28,118,579 from $27,182,095, though financing provided $20,944,670. Shareholders' equity swung to a $1,258,592 deficit from a $16,488,176 surplus amid rising liabilities to $10,441,013.

• ·Loss from operations worsened to $(40,167,308) from $(16,827,478).
• ·Other income declined to $448,161 from $19,606,351.
• ·Net cash provided by financing activities decreased to $20,944,670 from $27,875,809.
• ·Accounts payable increased to $2,543,415 from $1,737,463; accrued liabilities rose sharply to $7,868,416 from $480,962.
• ·Additional paid-in capital grew to $129,518,812 from $107,546,433.

25-03-2026

MineralRite Corp (RITE) filed its 10-K Annual Report on March 25, 2026, including consolidated financial statements (Balance Sheets on page 33, Statements of Operations on page 34, etc.) audited by Zhanna Kelley CPA PC. The audit report details standard procedures such as assessing risks of material misstatement, evaluating internal controls, accounting policies, and going concern status, with no substantial doubts or opinions on internal control effectiveness expressed. Critical audit matters addressed include purchase price allocation under ASC 805 and reasonableness of management's assumptions on future cash flows and fair value estimates.

• ·Audit firm address: 2323 Steinway Street, Long Island City, NY 11105; email: [email protected]; phone: 201-230-5498
• ·Financial statement pages: Balance Sheets (33), Statements of Operations (34), Stockholders’ Equity (35), Cash Flows (36), Notes (37)

25-03-2026

Stran & Company, Inc.'s 10-K highlights risks such as changes in trade regulations, tariffs, and product defects that could increase costs, limit imports, reduce demand, and harm revenue. However, it emphasizes strengths including over 30 years of history as a U.S. promotional products leader, a diversified base of over 2,000 active customers and 30+ Fortune 500 companies, with largest customer revenue share declining to 7.2% in 2025 from 8.4% in 2024 and top 10 at 35.7% from 38.1%. The company outlines growth plans like new client development, sales force expansion, and targeting acquisitions in the branded merchandise space with $5-10M revenue.

• ·Risks include trade regulation changes (e.g., with China) potentially increasing costs and limiting imports.
• ·Product defects could reduce demand, sales, market acceptance, and damage reputation.
• ·Sales and marketing focus on referrals, hiring experienced reps, SEO, HubSpot, tradeshows.
• ·Multiple U.S. warehouses support logistics for tradeshows, events, and e-commerce inventory management.

25-03-2026

Calisa Acquisition Corp, a SPAC, reported net income of $245,454 for the year ended December 31, 2025, versus a net loss of $79,422 for the period from inception (March 11, 2024) through December 31, 2024, driven by $429,224 in interest from the Trust Account after raising $60 million in its IPO. However, formation and operating costs rose 140% to $190,582, widening the operating loss from $79,459. Total assets grew to $61,017,446, primarily from $60,429,224 in the Trust Account, with 6,000,000 ordinary shares subject to redemption.

• ·Basic and diluted net income per share for redeemable ordinary shares: $0.07 (2025) vs $0 (2024)
• ·Basic and diluted net income per share for non-redeemable ordinary shares: $0.07 (2025) vs $(0.04) (2024)
• ·Shareholders’ Equity increased to $503,036 at Dec 31, 2025 from $73,578 at Dec 31, 2024

25-03-2026

X3 Acquisition Corp. Ltd., a blank check company formed on July 31, 2025, reported total assets of $247,558, primarily deferred offering costs, and total liabilities of $291,763 as of December 31, 2025, resulting in a shareholder's deficit of $44,205. The company recorded a net loss of $69,205 from formation and general administrative costs, with no revenue or cash on hand, as all activities were funded by the Sponsor through promissory notes and issuance of 5,750,000 Class B ordinary shares for $25,000. No initial business combination has occurred, and operations remain pre-IPO with focus on financial services sector targets.

• ·Net cash used in operating activities: $0; Cash at end of period: $0.
• ·Formation costs: $8,000 paid by Sponsor in exchange for shares; $46,705 via promissory note.
• ·Noncash: Deferred offering costs $21,305 accrued, $197,915 via promissory note, $17,000 via shares; Prepaid services $11,338 via promissory note.
• ·Basic and diluted net loss per Class B ordinary share: $(0.01).

25-03-2026

Lafayette Digital Acquisition Corp. I (ZKP), a SPAC formed on August 5, 2025, reported total assets of $188,624 as of December 31, 2025, consisting entirely of deferred offering costs. Liabilities totaled $221,697, including $135,369 in related-party promissory notes and $86,328 in accrued offering costs, resulting in a shareholders' deficit of $33,073. The company recorded a net loss of $58,073 from formation and administrative costs, with zero cash on hand and 9,583,333 Class B ordinary shares issued to the sponsor for $25,000.

• ·Basic and diluted net loss per Class B ordinary share: $(0.01)
• ·Non-cash deferred offering costs paid by Sponsor: $25,000
• ·Non-cash deferred offering costs through promissory note: $77,296